Sigma-1 Receptor as a Therapeutic Target for Fragile X Syndrome

Researchers will test sigma-1 receptor drugs—like fluvoxamine, which activates this pathway—to see if they can correct Fragile X brain cell abnormalities.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (37)